05 August, 2017
Want to see what other hedge funds are holding NVO?
Shares of Novo Nordisk A/S (NYSE NVO) traded down 1.01% during midday trading on Friday, hitting $42.06. About shares traded. Novo Nordisk A S (ADR) (NYSE:NVO) has declined 23.93% since August 4, 2016 and is downtrending.
Bernard Horn increased its stake in Allete (ALE) by 37.31% based on its latest 2016Q4 regulatory filing with the SEC. The Boston Advisors Llc holds 10,700 shares with $384,000 value, down from 22,725 last quarter. Tower Research Capital LLC TRC now owns 3,061 shares of the company's stock valued at $105,000 after buying an additional 1,918 shares in the last quarter. The company has a market capitalization of $107.54 billion, a P/E ratio of 18.30 and a beta of 0.63. The stock decreased 0.18% or $0.13 during the last trading session, reaching $73.62. Packaging Corp Of America (NYSE:PKG) has risen 54.92% since August 4, 2016 and is uptrending. It has underperformed by 16.70% the S&P500. DNB Markets downgraded Novo Nordisk A S (ADR) (NYSE:NVO) on Monday, October 31 to "Hold" rating.
More interesting news about Novo Nordisk A S (ADR) (NYSE:NVO) were released by: Fool.com and their article: "Why Novo Nordisk A/S (ADR) Jumped 10.6% In May" published on June 10, 2017 as well as Globenewswire.com's news article titled: "SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action ..." with publication date: January 25, 2017.
LLC maintained its position in Novo Nordisk A/S (NYSE:NVO) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). After $0.58 actual EPS reported by Novo Nordisk A S (ADR) for the previous quarter, Wall Street now forecasts -3.45% negative EPS growth. Cue Financial Group Inc. purchased a new stake in shares of Novo Nordisk A/S during the second quarter valued at $220,000.
Among 4 analysts covering Washington Trust Bancorp (NASDAQ:WASH), 1 have Buy rating, 0 Sell and 3 Hold. Therefore 31% are positive. HSBC Holdings plc downgraded shares of Novo Nordisk A/S from a "hold" rating to a "reduce" rating in a report on Friday, April 7th.
A number of brokerages have issued reports on NVO. Morgan Stanley downgraded Novo Nordisk A S (ADR) (NYSE:NVO) on Thursday, September 1 to "Equal-Weight" rating. The rating was downgraded by UBS on Monday, February 8 to "Sell". BNP Paribas upgraded the stock to "Outperform" rating in Tuesday, September 13 report. TheStreet raised Novo Nordisk A/S from a "c+" rating to a "b-" rating in a research report on Tuesday, May 2nd. Piper Jaffray initiated the shares of NVO in report on Friday, September 23 with "Neutral" rating. Zacks upgraded Novo Nordisk A S (ADR) (NYSE:NVO) rating on Friday, August 28. The firm earned "Underweight" rating on Wednesday, March 30 by JP Morgan. Novo Nordisk A/S now has an average rating of "Hold" and an average price target of $53.00.
Investors sentiment decreased to 1.05 in Q4 2016. Its up 0.31, from 1.05 in 2016Q3.
Other analysts have also recently issued reports about the company. 34 funds opened positions while 68 raised stakes. Us State Bank De invested in 0.01% or 36,535 shares. Merck & Co Inc New Com (NYSE:MRK) was raised too. Sei holds 75,480 shares or 0.02% of its portfolio. 50,000 were accumulated by Polar Asset Management Prns. Fdx reported 5,546 shares. Wedge Cap Management L LP Nc has 6,131 shares for 0% of their portfolio. They expect $0.56 EPS, down 6.67% or $0.04 from last year's $0.6 per share. California Employees Retirement Sys owns 31,400 shares for 0% of their portfolio. Clarivest Asset Mngmt reported 47,500 shares. Btim owns 0.13% invested in Washington Trust Bancorp (NASDAQ:WASH) for 140,836 shares. Principal Group Incorporated Inc holds 0.02% or 340,308 shares in its portfolio. "Ends Its Sales Slide" on August 09, 2016. Baldwin Brothers Inc. MA now owns 21,936 shares of the company's stock worth $752,000 after buying an additional 7,778 shares during the period.
Receive Novo Nordisk A/S News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novo Nordisk A/S with MarketBeat.com's FREE daily email newsletter.
